Polygenic scores are generating considerable debate in the biomedical and healthcare communities. Can they or can they not provide information that can be used in the prevention of common complex diseases. And is that information any good?
We have distilled findings from our extensive independent research (highlighted in Genome UK: 2022 to 2025 implementation plan for England) into a series of briefing notes for anyone needing a clear and concise understanding of the fundamental issues around polygenic scores and potential ways to resolve them.
Related content
